Comparing ChronoScale Corporation Common Stock (NASDAQ:CHRN) & Globus Medical (NYSE:GMED)

Globus Medical (NYSE:GMED) and ChronoScale Corporation Common Stock (NASDAQ:CHRN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Profitability

This table compares Globus Medical and ChronoScale Corporation Common Stock’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Globus Medical	18.30%	12.57%	10.87%
ChronoScale Corporation Common Stock	-135.66%	-197.81%	-74.17%

Institutional and Insider Ownership

95.2% of Globus Medical shares are held by institutional investors. Comparatively, 6.4% of ChronoScale Corporation Common Stock shares are held by institutional investors. 18.4% of Globus Medical shares are held by company insiders. Comparatively, 6.9% of ChronoScale Corporation Common Stock shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility and Risk

Globus Medical has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, ChronoScale Corporation Common Stock has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and price targets for Globus Medical and ChronoScale Corporation Common Stock, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0	5	8	3	2.88
ChronoScale Corporation Common Stock	1	1	0	0	1.50

Globus Medical currently has a consensus target price of $104.36, suggesting a potential upside of 16.86%. ChronoScale Corporation Common Stock has a consensus target price of $6.00, suggesting a potential downside of 49.79%. Given Globus Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Globus Medical is more favorable than ChronoScale Corporation Common Stock.

Earnings and Valuation

This table compares Globus Medical and ChronoScale Corporation Common Stock”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.94 billion	4.11	$537.87 million	$3.94	22.67
ChronoScale Corporation Common Stock	$12.80 million	3.32	-$11.69 million	($5.38)	-2.22

Globus Medical has higher revenue and earnings than ChronoScale Corporation Common Stock. ChronoScale Corporation Common Stock is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Globus Medical beats ChronoScale Corporation Common Stock on 15 of the 15 factors compared between the two stocks.

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.